Search tips
Search criteria 


Logo of uegLink to Publisher's site
United European Gastroenterol J. 2017 March; 5(2): 304.
Published online 2017 March 1. doi:  10.1177/2050640616641615
PMCID: PMC5349357


Robin Spiller, Fanny Pélerin, Amélie Cayzeele Decherf, Corinne Maudet, Béatrice Housez, Murielle Cazaubiel and Peter Jüsten. Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation. United European Gastroenterology Journal 2016; 4: 353–362. doi: 10.1177/2050640615602571.

On page 357, in the section “Results on total population”, the abdominal pain/discomfort scores observed in both active and placebo groups have been inverted. This should read as:

“Considering abdominal pain/discomfort score, significant decrease was observed from the beginning to the end of supplementation, in both active and placebo groups (respectively, −0.61 and −0.43, p < 0.0001 in both groups).”

Articles from United European Gastroenterology Journal are provided here courtesy of SAGE Publications